These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4062591)

  • 1. [Treatment of primary hyperlipidemia with 5-methylpyrazinecarboxylic acid (acipimox)].
    Quintão EC; de Castilho LN
    Arq Bras Cardiol; 1985 Jan; 44(1):37-40. PubMed ID: 4062591
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acipimox (Olbetam) as a secondary hypolipemic agent in combined hypertriglyceridemia and hyperlipidemia].
    Yeshurun D; Hamood H; Morad N; Naschitz J
    Harefuah; 2000 Apr; 138(8):650-3, 710. PubMed ID: 10883206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acipimox in primary hyperlipidemias: safety and efficacy evaluated in six months].
    Davidoff P; Ruiz F; Varas MA; García de los Ríos M; Silva MA; González G; Tapia JC
    Rev Med Chil; 1991 Oct; 119(10):1140-6. PubMed ID: 1845208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia.
    Fogari R; Marasi G; Vanasia A; Zoppi A; Lusardi P; Preti P
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):61-4. PubMed ID: 9147709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemia.
    Hoogerbrugge N; Jansen H; De Heide L; Zillikens MC; Deckers JW; Birkenhäger JC
    J Intern Med; 1997 Feb; 241(2):151-5. PubMed ID: 9077372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acipimox treatment of hyperlipidemia type II].
    Noseda G; Fragiacomo C; Cairoli R
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1790-1. PubMed ID: 6758114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of efficacy and safety of etofibrate in primary hyperlipidemia. A multicenter study].
    dos Santos JE; Loures-Vale AA; Novazzi JP; Rabelo LM; Martinez TL
    Arq Bras Cardiol; 1996 Dec; 67(6):419-22. PubMed ID: 9246832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acipimox--a nicotinic acid analogue for hyperlipidaemia.
    Drug Ther Bull; 1991 Jul; 29(15):57-9. PubMed ID: 1914867
    [No Abstract]   [Full Text] [Related]  

  • 10. The additional effects of acipimox to simvastatin in the treatment of combined hyperlipidaemia.
    Hoogerbrugge N; Jansen H; De Heide L; Zillikens MC; Deckers JW; Birkenhäger JC
    J Intern Med; 1998 May; 243(5):151-6. PubMed ID: 9651568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN; Poliakova ED; Olfer'ev AM; Perova NV
    Biull Eksp Biol Med; 1998 May; 125(5):569-73. PubMed ID: 9644562
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug treatment of hyperlipidemia].
    Noseda G
    Ther Umsch; 1987 Aug; 44(8):578-83. PubMed ID: 3672411
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
    Honorato J; Masso RM; Purroy A
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
    [No Abstract]   [Full Text] [Related]  

  • 14. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
    Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
    An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipoproteinemia: diagnosis and management.
    Shakir KM
    Prim Care; 1976 Jun; 3(2):277-91. PubMed ID: 1047448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT
    Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
    Oriente P; Motolese M; Cerqua R; Mancini M
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical effectiveness of acipimox and fenofibrate in patients with hyperlipoproteinemia type II].
    Chojnowska-Jezierska J; Jabłoński S; Tkaczewski W
    Wiad Lek; 1993 May; 46(9-10):332-6. PubMed ID: 8236987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A scheme for the treatment of hyperlipidemia.
    Spencer JM; Hutchinson RG; Hill JE
    J Miss State Med Assoc; 1990 Apr; 31(4):111-6. PubMed ID: 2332888
    [No Abstract]   [Full Text] [Related]  

  • 20. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.